Human Fibroblast Growth Factor-9 Recombinant

CAT:
421-90135-B
Size:
20 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Human Fibroblast Growth Factor-9 Recombinant - image 1

Human Fibroblast Growth Factor-9 Recombinant

  • Background:

    FGF-9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. FGF-9 induces osteoblast proliferation and new bone formation in a bone organ assay. FGF-9 is produced by many prostate cancer cells and contributes to prostate cancer-induced new bone formation and may participate in the osteoblastic progression of prostate cancer in bone. It is also an autocrine and/or paracrine neurotrophic factor that promotes the survival of motoneurons and upregulates choline acetyl-transferase activity. FGF-9 enhances survival of AChE-positive neurons, increasing their mean soma size. It also up-regulates their choline acetyltransferase activity as potently as NGF and the effect is greater than that elicited by bFGF, CNTF, or GDNF. FGF-9 acts as a survival factor for neurons but does not promote neurite outgrowth. FGF-9 has been shown to mediate its effects by binding to FGF receptors. It efficiently activates the FGFR2c splice form of FGFR2 and the FGFR3b and FGFR3c splice isoforms of FGFR3.
  • Description:

    Recombinant Fibroblast Growth Factor-9 is a disulfide-linked monomer protein consisting of 208 amino acid residues, and migrates as an approximately 23 kDa protein under non-reducing and reducing conditions in SDS-PAGE.
  • UniProt:

    P31371
  • Endotoxin:

    < 0.1 ng/µg (1 EU/µg), using the LAL gel clot method.
  • Purity:

    ≥ 95% by SDS-PAGE and HPLC
  • Format:

    Lyophilized protein
  • Reconstitution:

    Reconstitute at 0.1-1.0 mg/ml in distilled water. This solution can then be diluted into other buffers. To maximize product collection from vial surface, vortex briefly and then spin down to recollect the liquid.
  • Shipping Conditions:

    Gel Packs or Dry Ice
  • Storage Conditions:

    The lyophilized protein is stable for at least 2 years from date of receipt when stored at -20°C. Upon reconstitution, store in working aliquots at +4°C for up to one month, or at -20°C for up to six months, in the presence of a carrier protein. Avoid repeated freeze/thaw cycles.
  • Calculated Molecular Weight:

    23 kDa
  • Formulation:

    Lyophilized from 0.2 µm filtered PBS solution.